'Significant problems' at outsourcing sites prompt Trump to plan FDA budget boost 19-Feb-2020 By Nick Taylor President Trump proposes extra cash for US FDA to address “significant problems at many inspected outsourcing facilities.”
FDA puts spotlight on compounded drugs, opens educational center 07-Jan-2020 By Vassia Barba In an aim to improve quality assurance and control of compounded medicine, the US FDA opens a Compounding Quality Center of Excellence.
Endo ends suit against FDA over compounding case 01-Oct-2019 By Ben Hargreaves After receiving a favorable outcome against rival compounders, Endo decides to drop its case against the FDA regarding its Vasostrict product.
FDA to ‘institutionalize’ compounding regulation to ‘protect consumers’ 19-Jun-2019 By Nick Taylor The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching patients.